RSNA 2011 

Abstract Archives of the RSNA, 2011


LL-GIS-MO

Gastrointestinal

Scientific Informal (Poster) Presentations

Presented on November 28, 2011

Participants

Mustafa Rifaat Bashir MD, Presenter: Research grant, Bracco Group

Sub-Events

LL-GIS-MO10A     Noninvasive Subharmonic-aided Pressure Estimation in Patients with Suspected Portal Hypertension: Preliminary Results
Flemming Forsberg PhD | Valgerdur Halldorsdottir MSC | John Eisenbrey PhD | Jaydev Dave | Jose Gonzalez MD | Cynthia Miller RN | Daniel Merton | Priscilla Machado MD | Suhyun Park PhD | Scott Dianis MSc | Carl Chalek PhD | Kai Thomenius PhD | Daniel Brown MD | Victor Navarro

LL-GIS-MO10B     MRI for Characterization of Primary Tumors in the Non-cirrhotic Liver: Added Value of Gd-EOB-DTPA Enhanced Hepatospecific Phase
Michael Fischer MD | Olivio Donati MD | Roger Hunziker | Stefan Breitenstein | Dimitri Raptis | Michael Patak MD

LL-GIS-MO11A     Safety of an Intercostal Approach for Imaging-guided Percutaneous Drainage of Subdiaphragmatic Abscesses
Rendon Nelson MD | Tracy Jaffe MD | Mustafa Bashir MD | Stephen Preece MD | Clare Haystead MD

LL-GIS-MO1A     Is 3 Tesla MRI Superior to 64-row CT in Diagnosis of Hepatocellular Carcinoma?
Bettina Maiwald MMed | Donald Lobsien MD | Thomas Kahn MD | Patrick Stumpp MD, PhD

LL-GIS-MO1B     Assessing Necroinflammatory Activity and Fibrosis of the Liver Using Proton MR Spectroscopy in Patients with Chronic Liver Damage
Haruo Watanabe MD | Satoshi Goshima MD, PhD | Hiroshi Kawada MD | Hiroshi Kondo MD | Masayuki Kanematsu MD | Kyongtae Bae MD, PhD

LL-GIS-MO2A     Hypovascular Nodules on the Hepatobiliary Phase of Gd-EOB-DTPA-enhanced MRI in the Cirrhotic Liver: Baseline Patient Characteristics, MRI Findings, and Tumor Growth Kinetics for Prediction of Hypervascularization
Masahiro Okada MD | Yasuharu Imai | Masatoshi Kudo | Takamichi Murakami MD, PhD | Tomoko Hyodo MD | Yuki Kagawa MD | Seishi Kumano MD | Teruhito Mochizuki MD | Masatoshi Hori MD | Sachiyo Kogita

LL-GIS-MO2B     Diffusion-weighted MR Imaging with Navigator-triggered Prospective Acquisition Correction at 3 T for the Assessment of Hepatic Fibrosis
Yasuaki Kuginuki MD | Hisao Tonami MD | Mikihiro Tsutsumi | Tomiyasu Arisawa MD

LL-GIS-MO3A     MR Perfusion Imaging for the Prediction of Treatment Response after Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer
Joonseok Lim MD | Daehong Kim | Song-Ee Baek

LL-GIS-MO3B     Accuracy of Hepatic Fat Fraction Measurement Using the Multiecho Dixon Method with and without T2* Correction: Phantom and Clinical Study
Norio Hayashi PhD | Osamu Matsui MD | Yasuji Ryu MD | Shigeru Sanada PhD | Masako Takanaga | Takashi Hamaguchi MS | Tosiaki Miyati PhD | Naoki Ohno MS | Yumie Takeshita | Tsuyoshi Matsuda BS | Toshinari Takamura | Hiroji Iida

LL-GIS-MO4A     Ultrasound for Appendicitis: Clinical and Imaging Implications of Nonvisualization of the Appendix
R. Brooke Jeffrey MD | Jessica Stewart MD | Jarrett Rosenberg PhD | Eric Olcott MD

LL-GIS-MO4B     An Indigenous Standardized Ultrasound Scoring System for Preoperative Prediction of Difficult Laparoscopic Cholecystectomy
Mohammed Azfar Siddiqui MBBS, MD | Syed Amjad Ali Rizvi | Ekram Ullah | Shagufta Wahab | Ibne Ahmad

LL-GIS-MO5A     Efficiency of Diffusion MRI in Detection of Colorectal Tumor Recurrences
Murat Danaci | Ahmet Soyucok | Nilgun Okumus | Mehmet Nural

LL-GIS-MO5B     Videofluoroscopy Swallowing Study in Patients with Pharyngeal Stasis of Contrast Medium
Stefano Doratiotto MD | Giovanni Morana MD | Simonetta De Giorgi MD | Massimo Pasian

LL-GIS-MO6A     Contrast-enhanced CT Evaluation of Hepatic Metastases in Breast Cancer Patients Undergoing Chemotherapy, Targeted Therapy, or Combination
Chusilp Charnsangavej MD | Wei Yang MD | Hongying He MD, PhD | Richard Theriault DO | Marjorie Green | Mohammad Quraishi

LL-GIS-MO6B     The Value of 3-minute Delay Phase in Routine Oncology Follow-up MDCT for Hepatic Lesion Detection and Characterization
Bettina Siewert MD | Vassilios Raptopoulos MD | Olga Brook MD | Mishal Mendiratta-Lala MD | Sofia Gourtsoyianni MD

LL-GIS-MO7A     The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinomas: A Retrospective Study
David Liu | Andy Chan MD | Stephen Ho MD | Alison Harris MBChB

LL-GIS-MO7B     Increasing Uniformity of Ablation Zone in the Liver Using 3D Ultrasound
Nirmal Kakani MD | Derek Cool MD, PhD | Aaron Fenster PhD | Hamid Reza Sadeghi Neshat MSc | Cesare Romagnoli MD | Rohit Joshi MD,BEng | Amol Mujoomdar MD

LL-GIS-MO8A     Quantification of Total Liver Fat Volume Using MRI-determined Proton Density Fat Fraction and Whole Liver Segmentation on MR at 3.0 T
Claude Sirlin MD | Christopher Changchien BS | Arian Mashhood BS | Tanya Wolfson MS | Irene Cruite MD | Takeshi Yokoo MD, PhD | Michael Middleton PhD, MD | Gavin Hamilton PhD | Mark Bydder PhD | Michael Schroeder BS | Yauk Lee MD | Emmanuil Smorodinsky MD | Joshua Chen BS

LL-GIS-MO8B     Simultaneous Comparison of Gallbladder Ejection Fractions Measured by 3D Ultrasound and Cholescintigraphy
John Knudsen MD | Matthew Callstrom MD, PhD | Grant Schmit MD | John Schmitz MD | Duane Meixner | Rickey Carter PhD | Douglas Collins MD

LL-GIS-MO9A     Reproducibility of MR Imaging-determined Proton Density Fat Fraction (PDFF) across Different MR Scanner Platforms
Claude Sirlin MD | Geraldine Chang MD | Tanya Wolfson MS | Lisa Clark MPH, PhD | Michael Middleton PhD, MD | Gavin Hamilton PhD | Mark Bydder PhD | Anthony Gamst PhD

LL-GIS-MO9B     Agreement between MRI and MRS Fat Fraction Measurement in HIV Lipodystrophy-associated Fatty Liver Disease
Claude Sirlin MD | Michael Middleton PhD, MD | Adrienne Schlang MD | Daniel Lee MD | Gavin Hamilton PhD

Cite This Abstract

Bashir, M, Gastrointestinal.  Radiological Society of North America 2011 Scientific Assembly and Annual Meeting, November 26 - December 2, 2011 ,Chicago IL. http://archive.rsna.org/2011/11032831.html